Screening of drugs to counteract human papillomavirus 16 E6 repression of E-cadherin expression.

Investigational New Drugs
Zarina J D'CostaMerilyn H Hibma

Abstract

Persistent infections with certain high-risk human papillomavirus (HPV) types such as 16 and 18 can result in the development of cervical cancer. Neither of the two prophylactic vaccines against HPV16 and 18 that are in current use have any therapeutic efficacy for prevalent HPV infections. Ablative therapy is widely used for the treatment of HPV cervical dysplasia however disease recurrence is a widely recognized problem. Thus there is a continuing need for therapeutic approaches for the treatment of HPV infections. The HPV16 E6 viral oncoprotein represses surface expression of the cellular adhesion molecule, E-cadherin. Reduced E-cadherin expression on HPV-infected keratinocytes is associated with lowered numbers of antigen-presenting Langerhans cells in the infected epidermis, potentially reducing immune surveillance for HPV. Four chemicals reported to up-regulate E-cadherin were screened for their ability to counteract E6 repression of surface E-cadherin. 5-Aza-2'-deoxycytidine (AzaDC), a DNA methyltransferase inhibitor, and Indole-3-carbinol (I3C), reported to increase E-cadherin through a p21(Waf1/Cip1)-dependent mechanism, had low cytotoxicity and increased or restored E-cadherin expression and adhesive function in HPV16...Continue Reading

References

Apr 1, 1991·The Journal of Cell Biology·U H FrixenW Birchmeier
Jun 6, 1990·Journal of the National Cancer Institute·J J Michnovicz, H L Bradlow
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M OzawaR Kemler
Jan 1, 1989·Annual Review of Biochemistry·L F Liu
Jan 1, 1981·Leukemia Research·G E RivardL F Momparler
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·K YoshiuraS Hirohashi
Oct 9, 1998·Obstetrics and Gynecology·J MelnikowL P Howell
Mar 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P WijermansA Ferrant
Aug 6, 2000·Gynecologic Oncology·M C BellJ M Mathis
Nov 30, 2000·Breast Cancer Research and Treatment·Q MengS Fan
Dec 18, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·R L Momparler, J Ayoub
May 15, 2002·Diseases of the Colon and Rectum·Stephen E GoldstoneJohn R Neefe
May 20, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C L ChenH Y S Ngan
Jan 9, 2004·Expert Review of Vaccines·Margaret Stanley
Jan 1, 1997·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·W P Soutter
Feb 16, 2005·Anti-cancer Drugs·Maryse LemaireRichard L Momparler
Feb 16, 2005·Apoptosis : an International Journal on Programmed Cell Death·Xueli FanJason J Chen
Jul 5, 2005·Journal of Immunological Methods·Cheng-Mee Leong, Merilyn H Hibma
Sep 10, 2005·International Journal of Cancer. Journal International Du Cancer·Christine T BrewGary L Firestone
Sep 5, 2006·Vaccine·D Maxwell Parkin, Freddie Bray
Feb 3, 2007·Molecular Cancer Therapeutics·William C ReinholdJohn N Weinstein
Jan 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marij J P WeltersSjoerd H van der Burg
Feb 12, 2008·Current Protocols in Molecular Biology·Angie L BookoutMartha F Kramer
Apr 4, 2008·The New England Journal of Medicine·Manon van SetersTheo J M Helmerhorst
May 6, 2008·BMC Cancer·Maryse LemaireRichard L Momparler
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ursula WintersHenry C Kitchener

❮ Previous
Next ❯

Citations

Nov 29, 2012·PloS One·Zarina J D'CostaMerilyn H Hibma
May 29, 2013·Virology·Scott B Vande Pol, Aloysius J Klingelhutz
Jul 15, 2015·Expert Review of Anticancer Therapy·Daniela L Buscariollo, Harvey J Mamon
Aug 1, 2019·International Journal of Oncology·Yu LiuXiaorong Qi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.